NO302664B1 - Enzymatisk prosess for bestemmelse av <beta>-lactamantibiotika - Google Patents
Enzymatisk prosess for bestemmelse av <beta>-lactamantibiotika Download PDFInfo
- Publication number
- NO302664B1 NO302664B1 NO911692A NO911692A NO302664B1 NO 302664 B1 NO302664 B1 NO 302664B1 NO 911692 A NO911692 A NO 911692A NO 911692 A NO911692 A NO 911692A NO 302664 B1 NO302664 B1 NO 302664B1
- Authority
- NO
- Norway
- Prior art keywords
- enzyme
- antibiotic
- acid
- substrate
- alanyl
- Prior art date
Links
- 238000000034 method Methods 0.000 title claims abstract description 143
- 230000008569 process Effects 0.000 title claims description 72
- 230000002255 enzymatic effect Effects 0.000 title claims description 23
- 239000003782 beta lactam antibiotic agent Substances 0.000 title description 17
- 239000000758 substrate Substances 0.000 claims abstract description 50
- 239000013060 biological fluid Substances 0.000 claims abstract description 44
- 238000012360 testing method Methods 0.000 claims abstract description 41
- 239000002253 acid Substances 0.000 claims abstract description 40
- 238000011534 incubation Methods 0.000 claims abstract description 32
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 claims abstract description 23
- 239000003153 chemical reaction reagent Substances 0.000 claims abstract description 20
- 150000007970 thio esters Chemical class 0.000 claims abstract description 14
- -1 phenylacetyl Chemical group 0.000 claims abstract description 11
- 102000030899 Serine-Type D-Ala-D-Ala Carboxypeptidase Human genes 0.000 claims abstract description 10
- 108010004832 Serine-Type D-Ala-D-Ala Carboxypeptidase Proteins 0.000 claims abstract description 10
- 239000000203 mixture Substances 0.000 claims abstract description 9
- 241000187362 Actinomadura Species 0.000 claims abstract description 7
- 125000003630 glycyl group Chemical group [H]N([H])C([H])([H])C(*)=O 0.000 claims abstract description 5
- 125000003236 benzoyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C(*)=O 0.000 claims abstract description 4
- 102000004190 Enzymes Human genes 0.000 claims description 96
- 108090000790 Enzymes Proteins 0.000 claims description 96
- 230000003115 biocidal effect Effects 0.000 claims description 65
- JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 claims description 48
- 235000013336 milk Nutrition 0.000 claims description 47
- 210000004080 milk Anatomy 0.000 claims description 47
- 239000008267 milk Substances 0.000 claims description 47
- QNAYBMKLOCPYGJ-UHFFFAOYSA-N D-alpha-Ala Natural products CC([NH3+])C([O-])=O QNAYBMKLOCPYGJ-UHFFFAOYSA-N 0.000 claims description 24
- QNAYBMKLOCPYGJ-UWTATZPHSA-N D-alanine Chemical compound C[C@@H](N)C(O)=O QNAYBMKLOCPYGJ-UWTATZPHSA-N 0.000 claims description 23
- 229940056360 penicillin g Drugs 0.000 claims description 22
- 238000006460 hydrolysis reaction Methods 0.000 claims description 21
- 230000007062 hydrolysis Effects 0.000 claims description 18
- 150000008574 D-amino acids Chemical class 0.000 claims description 17
- OEJDVGZWJKPUDA-MRVPVSSYSA-N 2-[(2r)-2-benzamidopropanoyl]sulfanylacetic acid Chemical group OC(=O)CSC(=O)[C@@H](C)NC(=O)C1=CC=CC=C1 OEJDVGZWJKPUDA-MRVPVSSYSA-N 0.000 claims description 11
- 239000004471 Glycine Substances 0.000 claims description 11
- 239000007864 aqueous solution Substances 0.000 claims description 10
- 210000002966 serum Anatomy 0.000 claims description 10
- 239000000243 solution Substances 0.000 claims description 6
- UQLLWWBDSUHNEB-CZUORRHYSA-N Cefaprin Chemical compound N([C@H]1[C@@H]2N(C1=O)C(=C(CS2)COC(=O)C)C(O)=O)C(=O)CSC1=CC=NC=C1 UQLLWWBDSUHNEB-CZUORRHYSA-N 0.000 claims description 5
- MTCFGRXMJLQNBG-UWTATZPHSA-N D-Serine Chemical compound OC[C@@H](N)C(O)=O MTCFGRXMJLQNBG-UWTATZPHSA-N 0.000 claims description 5
- 229930195711 D-Serine Natural products 0.000 claims description 5
- QWCKQJZIFLGMSD-GSVOUGTGSA-N D-alpha-aminobutyric acid Chemical compound CC[C@@H](N)C(O)=O QWCKQJZIFLGMSD-GSVOUGTGSA-N 0.000 claims description 5
- HNDVDQJCIGZPNO-RXMQYKEDSA-N D-histidine Chemical compound OC(=O)[C@H](N)CC1=CN=CN1 HNDVDQJCIGZPNO-RXMQYKEDSA-N 0.000 claims description 5
- 229930195721 D-histidine Natural products 0.000 claims description 5
- FFEARJCKVFRZRR-SCSAIBSYSA-N D-methionine Chemical compound CSCC[C@@H](N)C(O)=O FFEARJCKVFRZRR-SCSAIBSYSA-N 0.000 claims description 5
- 229930182818 D-methionine Natural products 0.000 claims description 5
- COLNVLDHVKWLRT-MRVPVSSYSA-N D-phenylalanine Chemical compound OC(=O)[C@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-MRVPVSSYSA-N 0.000 claims description 5
- 229930182832 D-phenylalanine Natural products 0.000 claims description 5
- 229960004350 cefapirin Drugs 0.000 claims description 5
- 239000012530 fluid Substances 0.000 claims description 5
- 239000007788 liquid Substances 0.000 claims description 5
- 210000002700 urine Anatomy 0.000 claims description 5
- ODKSFYDXXFIFQN-SCSAIBSYSA-N D-arginine Chemical compound OC(=O)[C@H](N)CCCNC(N)=N ODKSFYDXXFIFQN-SCSAIBSYSA-N 0.000 claims description 4
- 229930028154 D-arginine Natural products 0.000 claims description 4
- QIVBCDIJIAJPQS-SECBINFHSA-N D-tryptophane Chemical compound C1=CC=C2C(C[C@@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-SECBINFHSA-N 0.000 claims description 4
- KZSNJWFQEVHDMF-SCSAIBSYSA-N D-valine Chemical compound CC(C)[C@@H](N)C(O)=O KZSNJWFQEVHDMF-SCSAIBSYSA-N 0.000 claims description 4
- 229930182831 D-valine Natural products 0.000 claims description 4
- HOKIDJSKDBPKTQ-GLXFQSAKSA-N cephalosporin C Chemical compound S1CC(COC(=O)C)=C(C(O)=O)N2C(=O)[C@@H](NC(=O)CCC[C@@H](N)C(O)=O)[C@@H]12 HOKIDJSKDBPKTQ-GLXFQSAKSA-N 0.000 claims description 4
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims description 4
- WCYWZMWISLQXQU-UHFFFAOYSA-N methyl Chemical compound [CH3] WCYWZMWISLQXQU-UHFFFAOYSA-N 0.000 claims description 4
- 210000003296 saliva Anatomy 0.000 claims description 4
- 229930182827 D-tryptophan Natural products 0.000 claims description 3
- 239000000284 extract Substances 0.000 claims description 3
- 238000000855 fermentation Methods 0.000 claims description 3
- 230000004151 fermentation Effects 0.000 claims description 3
- 230000002427 irreversible effect Effects 0.000 claims description 3
- 235000013372 meat Nutrition 0.000 claims description 3
- RJQXTJLFIWVMTO-TYNCELHUSA-N Methicillin Chemical compound COC1=CC=CC(OC)=C1C(=O)N[C@@H]1C(=O)N2[C@@H](C(O)=O)C(C)(C)S[C@@H]21 RJQXTJLFIWVMTO-TYNCELHUSA-N 0.000 claims description 2
- 229930195708 Penicillin V Natural products 0.000 claims description 2
- 229960000723 ampicillin Drugs 0.000 claims description 2
- AVKUERGKIZMTKX-NJBDSQKTSA-N ampicillin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(O)=O)(C)C)=CC=CC=C1 AVKUERGKIZMTKX-NJBDSQKTSA-N 0.000 claims description 2
- FPPNZSSZRUTDAP-UWFZAAFLSA-N carbenicillin Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)C(C(O)=O)C1=CC=CC=C1 FPPNZSSZRUTDAP-UWFZAAFLSA-N 0.000 claims description 2
- 229960003669 carbenicillin Drugs 0.000 claims description 2
- FUBBGQLTSCSAON-PBFPGSCMSA-N cefaloglycin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@@H]3N(C2=O)C(=C(CS3)COC(=O)C)C(O)=O)=CC=CC=C1 FUBBGQLTSCSAON-PBFPGSCMSA-N 0.000 claims description 2
- 229950004030 cefaloglycin Drugs 0.000 claims description 2
- XIURVHNZVLADCM-IUODEOHRSA-N cefalotin Chemical compound N([C@H]1[C@@H]2N(C1=O)C(=C(CS2)COC(=O)C)C(O)=O)C(=O)CC1=CC=CS1 XIURVHNZVLADCM-IUODEOHRSA-N 0.000 claims description 2
- 229960000603 cefalotin Drugs 0.000 claims description 2
- 229940106164 cephalexin Drugs 0.000 claims description 2
- ZAIPMKNFIOOWCQ-UEKVPHQBSA-N cephalexin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@@H]3N(C2=O)C(=C(CS3)C)C(O)=O)=CC=CC=C1 ZAIPMKNFIOOWCQ-UEKVPHQBSA-N 0.000 claims description 2
- 229960003326 cloxacillin Drugs 0.000 claims description 2
- LQOLIRLGBULYKD-JKIFEVAISA-N cloxacillin Chemical compound N([C@@H]1C(N2[C@H](C(C)(C)S[C@@H]21)C(O)=O)=O)C(=O)C1=C(C)ON=C1C1=CC=CC=C1Cl LQOLIRLGBULYKD-JKIFEVAISA-N 0.000 claims description 2
- 229960003085 meticillin Drugs 0.000 claims description 2
- UWYHMGVUTGAWSP-JKIFEVAISA-N oxacillin Chemical compound N([C@@H]1C(N2[C@H](C(C)(C)S[C@@H]21)C(O)=O)=O)C(=O)C1=C(C)ON=C1C1=CC=CC=C1 UWYHMGVUTGAWSP-JKIFEVAISA-N 0.000 claims description 2
- 229960001019 oxacillin Drugs 0.000 claims description 2
- 235000019371 penicillin G benzathine Nutrition 0.000 claims description 2
- 229940056367 penicillin v Drugs 0.000 claims description 2
- BPLBGHOLXOTWMN-MBNYWOFBSA-N phenoxymethylpenicillin Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)COC1=CC=CC=C1 BPLBGHOLXOTWMN-MBNYWOFBSA-N 0.000 claims description 2
- 150000001413 amino acids Chemical class 0.000 abstract description 3
- 125000000030 D-alanine group Chemical group [H]N([H])[C@](C([H])([H])[H])(C(=O)[*])[H] 0.000 abstract description 2
- 239000000523 sample Substances 0.000 description 49
- 239000003242 anti bacterial agent Substances 0.000 description 21
- 230000000694 effects Effects 0.000 description 20
- 230000035945 sensitivity Effects 0.000 description 19
- 229940088710 antibiotic agent Drugs 0.000 description 16
- 230000003287 optical effect Effects 0.000 description 12
- 239000012916 chromogenic reagent Substances 0.000 description 11
- 239000012190 activator Substances 0.000 description 9
- 239000013068 control sample Substances 0.000 description 9
- 229930182555 Penicillin Natural products 0.000 description 8
- 238000006243 chemical reaction Methods 0.000 description 7
- 239000002132 β-lactam antibiotic Substances 0.000 description 7
- 229940124586 β-lactam antibiotics Drugs 0.000 description 7
- 230000008901 benefit Effects 0.000 description 6
- 239000012496 blank sample Substances 0.000 description 6
- 238000001514 detection method Methods 0.000 description 6
- JKMHFZQWWAIEOD-UHFFFAOYSA-N 2-[4-(2-hydroxyethyl)piperazin-1-yl]ethanesulfonic acid Chemical compound OCC[NH+]1CCN(CCS([O-])(=O)=O)CC1 JKMHFZQWWAIEOD-UHFFFAOYSA-N 0.000 description 5
- 102000004674 D-amino-acid oxidase Human genes 0.000 description 5
- 108010003989 D-amino-acid oxidase Proteins 0.000 description 5
- 235000013365 dairy product Nutrition 0.000 description 5
- 229940049954 penicillin Drugs 0.000 description 5
- 230000000007 visual effect Effects 0.000 description 5
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 4
- TWRXJAOTZQYOKJ-UHFFFAOYSA-L Magnesium chloride Chemical compound [Mg+2].[Cl-].[Cl-] TWRXJAOTZQYOKJ-UHFFFAOYSA-L 0.000 description 4
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 4
- 230000015572 biosynthetic process Effects 0.000 description 4
- 238000004737 colorimetric analysis Methods 0.000 description 4
- VFUPLKGPCOIXET-SECBINFHSA-N 2-[(2r)-2-[(2-phenylacetyl)amino]propanoyl]sulfanylacetic acid Chemical compound OC(=O)CSC(=O)[C@@H](C)NC(=O)CC1=CC=CC=C1 VFUPLKGPCOIXET-SECBINFHSA-N 0.000 description 3
- GANZODCWZFAEGN-UHFFFAOYSA-N 5-mercapto-2-nitro-benzoic acid Chemical compound OC(=O)C1=CC(S)=CC=C1[N+]([O-])=O GANZODCWZFAEGN-UHFFFAOYSA-N 0.000 description 3
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 3
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 3
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 3
- 102000003992 Peroxidases Human genes 0.000 description 3
- 150000001875 compounds Chemical class 0.000 description 3
- 244000005700 microbiome Species 0.000 description 3
- 150000002960 penicillins Chemical class 0.000 description 3
- 108040007629 peroxidase activity proteins Proteins 0.000 description 3
- 239000000047 product Substances 0.000 description 3
- 238000000926 separation method Methods 0.000 description 3
- 238000011179 visual inspection Methods 0.000 description 3
- 238000004383 yellowing Methods 0.000 description 3
- JRBJSXQPQWSCCF-UHFFFAOYSA-N 3,3'-Dimethoxybenzidine Chemical compound C1=C(N)C(OC)=CC(C=2C=C(OC)C(N)=CC=2)=C1 JRBJSXQPQWSCCF-UHFFFAOYSA-N 0.000 description 2
- 241000283690 Bos taurus Species 0.000 description 2
- 229930186147 Cephalosporin Natural products 0.000 description 2
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
- 208000035473 Communicable disease Diseases 0.000 description 2
- LCTONWCANYUPML-UHFFFAOYSA-N Pyruvic acid Chemical compound CC(=O)C(O)=O LCTONWCANYUPML-UHFFFAOYSA-N 0.000 description 2
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 2
- 241000187747 Streptomyces Species 0.000 description 2
- 239000000872 buffer Substances 0.000 description 2
- 230000015556 catabolic process Effects 0.000 description 2
- 229940124587 cephalosporin Drugs 0.000 description 2
- 150000001780 cephalosporins Chemical class 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 239000003086 colorant Substances 0.000 description 2
- 238000012505 colouration Methods 0.000 description 2
- 230000007423 decrease Effects 0.000 description 2
- 238000006911 enzymatic reaction Methods 0.000 description 2
- VWWQXMAJTJZDQX-UYBVJOGSSA-N flavin adenine dinucleotide Chemical compound C1=NC2=C(N)N=CN=C2N1[C@@H]([C@H](O)[C@@H]1O)O[C@@H]1CO[P@](O)(=O)O[P@@](O)(=O)OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C2=NC(=O)NC(=O)C2=NC2=C1C=C(C)C(C)=C2 VWWQXMAJTJZDQX-UYBVJOGSSA-N 0.000 description 2
- 235000019162 flavin adenine dinucleotide Nutrition 0.000 description 2
- 239000011714 flavin adenine dinucleotide Substances 0.000 description 2
- 229940093632 flavin-adenine dinucleotide Drugs 0.000 description 2
- 229910001629 magnesium chloride Inorganic materials 0.000 description 2
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 239000002609 medium Substances 0.000 description 2
- 230000002906 microbiologic effect Effects 0.000 description 2
- 239000008055 phosphate buffer solution Substances 0.000 description 2
- 108090000765 processed proteins & peptides Proteins 0.000 description 2
- 230000002285 radioactive effect Effects 0.000 description 2
- 239000012857 radioactive material Substances 0.000 description 2
- 230000035484 reaction time Effects 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 238000012216 screening Methods 0.000 description 2
- 239000011780 sodium chloride Substances 0.000 description 2
- 238000010186 staining Methods 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- ZLLFKMLNHKUVOF-UHFFFAOYSA-N 2-(2-benzamidoacetyl)sulfanylacetic acid Chemical compound OC(=O)CSC(=O)CNC(=O)C1=CC=CC=C1 ZLLFKMLNHKUVOF-UHFFFAOYSA-N 0.000 description 1
- ZWNWWNCNMZXLEN-VEDVMXKPSA-N 2-[(2r)-2-benzamidopropanoyl]sulfanylpropanoic acid Chemical compound OC(=O)C(C)SC(=O)[C@@H](C)NC(=O)C1=CC=CC=C1 ZWNWWNCNMZXLEN-VEDVMXKPSA-N 0.000 description 1
- KIUMMUBSPKGMOY-UHFFFAOYSA-N 3,3'-Dithiobis(6-nitrobenzoic acid) Chemical compound C1=C([N+]([O-])=O)C(C(=O)O)=CC(SSC=2C=C(C(=CC=2)[N+]([O-])=O)C(O)=O)=C1 KIUMMUBSPKGMOY-UHFFFAOYSA-N 0.000 description 1
- 229910002012 Aerosil® Inorganic materials 0.000 description 1
- PAYRUJLWNCNPSJ-UHFFFAOYSA-N Aniline Chemical compound NC1=CC=CC=C1 PAYRUJLWNCNPSJ-UHFFFAOYSA-N 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 102000005367 Carboxypeptidases Human genes 0.000 description 1
- 108010006303 Carboxypeptidases Proteins 0.000 description 1
- DEFJQIDDEAULHB-QWWZWVQMSA-N D-alanyl-D-alanine Chemical group C[C@@H]([NH3+])C(=O)N[C@H](C)C([O-])=O DEFJQIDDEAULHB-QWWZWVQMSA-N 0.000 description 1
- 238000002965 ELISA Methods 0.000 description 1
- 241000193385 Geobacillus stearothermophilus Species 0.000 description 1
- 108010093096 Immobilized Enzymes Proteins 0.000 description 1
- 239000007836 KH2PO4 Substances 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 229920000168 Microcrystalline cellulose Polymers 0.000 description 1
- 108700017811 N-diacetyl-lysyl-alanyl-alanine N Proteins 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 102000005488 Thioesterase Human genes 0.000 description 1
- DGEZNRSVGBDHLK-UHFFFAOYSA-N [1,10]phenanthroline Chemical compound C1=CN=C2C3=NC=CC=C3C=CC2=C1 DGEZNRSVGBDHLK-UHFFFAOYSA-N 0.000 description 1
- QTBSBXVTEAMEQO-UHFFFAOYSA-N acetic acid Substances CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 230000004520 agglutination Effects 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 150000008064 anhydrides Chemical class 0.000 description 1
- 239000004599 antimicrobial Substances 0.000 description 1
- 239000012736 aqueous medium Substances 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 150000003935 benzaldehydes Chemical class 0.000 description 1
- 125000003460 beta-lactamyl group Chemical group 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 150000001768 cations Chemical class 0.000 description 1
- 125000001271 cephalosporin group Chemical group 0.000 description 1
- 235000013351 cheese Nutrition 0.000 description 1
- 238000002512 chemotherapy Methods 0.000 description 1
- 239000005515 coenzyme Substances 0.000 description 1
- 239000008119 colloidal silica Substances 0.000 description 1
- 239000007859 condensation product Substances 0.000 description 1
- 238000011109 contamination Methods 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 229910000396 dipotassium phosphate Inorganic materials 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 230000007717 exclusion Effects 0.000 description 1
- 235000012631 food intake Nutrition 0.000 description 1
- 239000005452 food preservative Substances 0.000 description 1
- 235000019249 food preservative Nutrition 0.000 description 1
- 239000001963 growth medium Substances 0.000 description 1
- 230000009931 harmful effect Effects 0.000 description 1
- 230000003301 hydrolyzing effect Effects 0.000 description 1
- 230000001900 immune effect Effects 0.000 description 1
- 230000003053 immunization Effects 0.000 description 1
- 238000002649 immunization Methods 0.000 description 1
- 239000012442 inert solvent Substances 0.000 description 1
- 150000003951 lactams Chemical class 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- 230000002045 lasting effect Effects 0.000 description 1
- 239000004816 latex Substances 0.000 description 1
- 229920000126 latex Polymers 0.000 description 1
- 235000019359 magnesium stearate Nutrition 0.000 description 1
- 208000004396 mastitis Diseases 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 235000019813 microcrystalline cellulose Nutrition 0.000 description 1
- 239000008108 microcrystalline cellulose Substances 0.000 description 1
- 229940016286 microcrystalline cellulose Drugs 0.000 description 1
- 229910000402 monopotassium phosphate Inorganic materials 0.000 description 1
- 235000019796 monopotassium phosphate Nutrition 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000000546 pharmaceutical excipient Substances 0.000 description 1
- 229920002939 poly(N,N-dimethylacrylamides) Polymers 0.000 description 1
- 229940093429 polyethylene glycol 6000 Drugs 0.000 description 1
- GNSKLFRGEWLPPA-UHFFFAOYSA-M potassium dihydrogen phosphate Chemical compound [K+].OP(O)([O-])=O GNSKLFRGEWLPPA-UHFFFAOYSA-M 0.000 description 1
- 230000002028 premature Effects 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 229940107700 pyruvic acid Drugs 0.000 description 1
- 238000011158 quantitative evaluation Methods 0.000 description 1
- 239000000376 reactant Substances 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 239000011347 resin Substances 0.000 description 1
- 229920005989 resin Polymers 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- GFWRVVCDTLRWPK-KPKJPENVSA-N sofalcone Chemical compound C1=CC(OCC=C(C)C)=CC=C1\C=C\C(=O)C1=CC=C(OCC=C(C)C)C=C1OCC(O)=O GFWRVVCDTLRWPK-KPKJPENVSA-N 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 229940124597 therapeutic agent Drugs 0.000 description 1
- 108020002982 thioesterase Proteins 0.000 description 1
- 235000013618 yogurt Nutrition 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06086—Dipeptides with the first amino acid being basic
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/34—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase
- C12Q1/37—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase involving peptidase or proteinase
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S435/00—Chemistry: molecular biology and microbiology
- Y10S435/81—Packaged device or kit
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S435/00—Chemistry: molecular biology and microbiology
- Y10S435/8215—Microorganisms
- Y10S435/822—Microorganisms using bacteria or actinomycetales
- Y10S435/825—Actinomadura
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S435/00—Chemistry: molecular biology and microbiology
- Y10S435/975—Kit
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S436/00—Chemistry: analytical and immunological testing
- Y10S436/815—Test for named compound or class of compounds
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Zoology (AREA)
- Molecular Biology (AREA)
- Wood Science & Technology (AREA)
- Analytical Chemistry (AREA)
- Microbiology (AREA)
- Physics & Mathematics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- Immunology (AREA)
- Biotechnology (AREA)
- Medicinal Chemistry (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Cephalosporin Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB909009692A GB9009692D0 (en) | 1990-04-30 | 1990-04-30 | An enzymatic method of determining beta-lactam ring antibiotics |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| NO911692D0 NO911692D0 (no) | 1991-04-29 |
| NO911692L NO911692L (no) | 1991-10-31 |
| NO302664B1 true NO302664B1 (no) | 1998-04-06 |
Family
ID=10675235
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO911692A NO302664B1 (no) | 1990-04-30 | 1991-04-29 | Enzymatisk prosess for bestemmelse av <beta>-lactamantibiotika |
Country Status (22)
| Country | Link |
|---|---|
| US (1) | US5246830A (ja) |
| EP (1) | EP0468946B1 (ja) |
| JP (1) | JP2823382B2 (ja) |
| AT (1) | ATE124998T1 (ja) |
| AU (1) | AU636482B2 (ja) |
| BG (1) | BG61082B2 (ja) |
| CA (1) | CA2040180C (ja) |
| CZ (1) | CZ280282B6 (ja) |
| DE (1) | DE69111149T2 (ja) |
| DK (1) | DK0468946T3 (ja) |
| ES (1) | ES2075414T3 (ja) |
| FI (1) | FI97151C (ja) |
| GB (1) | GB9009692D0 (ja) |
| GR (1) | GR3017235T3 (ja) |
| HU (1) | HU214926B (ja) |
| IE (1) | IE69037B1 (ja) |
| NO (1) | NO302664B1 (ja) |
| NZ (1) | NZ237950A (ja) |
| PL (1) | PL169360B1 (ja) |
| PT (1) | PT97511B (ja) |
| SK (1) | SK279176B6 (ja) |
| YU (1) | YU48050B (ja) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SI1023603T1 (sl) * | 1997-10-07 | 2005-12-31 | Ucb S A Ipd Dept | Testna naprava za detekcijo prisotnosti analitov v tekocih mlecnih izdelkih |
| US6143513A (en) * | 1999-06-23 | 2000-11-07 | Biacore Ab | Method and kit for detecting betalactam-containing compounds |
| PL385415A1 (pl) * | 2008-06-11 | 2009-12-21 | Marek Ciesielski | Sposób wykrywania bakteriooporności, zestaw diagnostyczny oraz zastosowanie oznaczania obecności leku i/lub produktów jego rozpadu |
| WO2013053953A1 (en) * | 2011-10-14 | 2013-04-18 | Université de Liège | Method for measuring beta-lactam antibiotics |
| CN111830015B (zh) * | 2019-04-18 | 2022-12-09 | 中国农业科学院农产品加工研究所 | 一种定量检测抗生素的方法 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2824863A (en) * | 1952-11-14 | 1958-02-25 | Ciba Pharm Prod Inc | Acylmercapto compounds |
| US4166825A (en) * | 1978-08-17 | 1979-09-04 | Abbott Laboratories | Chromogenic substrates |
| CA1185881A (en) * | 1982-02-01 | 1985-04-23 | Jacques Degelaen | ENZYMATIC PROCESS FOR THE DETERMINATION OF .beta.-LACTAM ANTIBIOTICS |
| US4806478A (en) * | 1984-10-17 | 1989-02-21 | Minnesota Mining And Manufacturing Company | Dry enzyme formulations containing D-amino acid oxidase |
| US4686182A (en) * | 1984-10-17 | 1987-08-11 | Minnesota Mining And Manufacturing Company | Method and kit for detecting antibiotics in a liquid sample |
-
1990
- 1990-04-30 GB GB909009692A patent/GB9009692D0/en active Pending
-
1991
- 1991-04-10 CA CA002040180A patent/CA2040180C/en not_active Expired - Lifetime
- 1991-04-26 EP EP91870070A patent/EP0468946B1/fr not_active Expired - Lifetime
- 1991-04-26 ES ES91870070T patent/ES2075414T3/es not_active Expired - Lifetime
- 1991-04-26 JP JP3096762A patent/JP2823382B2/ja not_active Expired - Fee Related
- 1991-04-26 PL PL91290061A patent/PL169360B1/pl unknown
- 1991-04-26 US US07/692,355 patent/US5246830A/en not_active Expired - Lifetime
- 1991-04-26 NZ NZ237950A patent/NZ237950A/en unknown
- 1991-04-26 DE DE69111149T patent/DE69111149T2/de not_active Expired - Lifetime
- 1991-04-26 AT AT91870070T patent/ATE124998T1/de not_active IP Right Cessation
- 1991-04-26 AU AU76226/91A patent/AU636482B2/en not_active Ceased
- 1991-04-26 DK DK91870070.9T patent/DK0468946T3/da active
- 1991-04-29 NO NO911692A patent/NO302664B1/no unknown
- 1991-04-29 IE IE143391A patent/IE69037B1/en not_active IP Right Cessation
- 1991-04-29 FI FI912054A patent/FI97151C/fi active
- 1991-04-29 HU HU911441A patent/HU214926B/hu not_active IP Right Cessation
- 1991-04-29 PT PT97511A patent/PT97511B/pt not_active IP Right Cessation
- 1991-04-29 BG BG094327A patent/BG61082B2/bg unknown
- 1991-04-30 YU YU78391A patent/YU48050B/sh unknown
- 1991-04-30 SK SK1246-91A patent/SK279176B6/sk unknown
- 1991-04-30 CZ CS911246A patent/CZ280282B6/cs not_active IP Right Cessation
-
1995
- 1995-08-30 GR GR950402344T patent/GR3017235T3/el unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US4945060A (en) | Device for detecting microorganisms | |
| CA2027536C (en) | Method for determination of e.coli in water | |
| JPH0648272B2 (ja) | グラム陰性細菌尿症のスクリーニング法 | |
| JPS6054698A (ja) | 細菌の感受性の試験方法および試験薬剤 | |
| JP2809537B2 (ja) | リステリア属の細菌を同定する方法及び媒質 | |
| US8404460B2 (en) | Method for detecting and/or identifying Clostridium difficile | |
| EP0025467B1 (en) | Chromogenic chemical substrates for identification of microbial colonies | |
| WO2011021008A1 (en) | Bioluminescent bacterial detection | |
| JP2001510054A (ja) | リステリア属病原性細菌検出用培養培地およびこの細菌の同定方法 | |
| US4340671A (en) | E. coli sensitivity broth | |
| JPS6156098A (ja) | 抗微生物活性物質の検出用試薬および検出方法 | |
| NO302664B1 (no) | Enzymatisk prosess for bestemmelse av <beta>-lactamantibiotika | |
| NO138183B (no) | Diagnosemiddel for bestemmelse av gammaglutamyl-transpeptidase i biologiske vaesker | |
| US4546076A (en) | Enzymatic process for the determination of beta-lactam antibiotics | |
| US10612068B2 (en) | Culture medium containing a spore germination inhibiting or delaying compound | |
| Lee et al. | Microbial detection of toxic compounds utilizing recombinant DNA technology and bioluminescence | |
| Thorogood et al. | An evaluation of the Penzym® assay: a rapid method for the detection of β‐lactam antibiotics in milk | |
| SU1497218A1 (ru) | Способ определени активности гликогенфосфорилазы | |
| SU1472507A1 (ru) | Способ определени контаминации производственных бактериальных культур | |
| SU1102812A1 (ru) | Питательна среда дл учета споровых анаэробных микроорганизмов-вредителей молочного производства | |
| Baker | Activity of penicillin acylase producing bacteria against α-aminobenzylpenicillins | |
| JP2002510504A (ja) | プロテイナーゼ基質として酵素を用いるプロテイナーゼ定量法 |